BrainChild Bio · Series A
Sr. Director of Finance
United States · Remote
$205K–$275K
Posted 16 days ago· Nov 4

Biotechnology, Health Care, Life Science, Neuroscience, Therapeutics
BrainChild Bio raised $116M in a Series A announced on Sep 8, 2026, led by WRF Capital, Seattle Children’s, ScaleReady. Since then it has posted 5 roles (4 still open), the first 28 days after it. Another 1 open role was posted before the announcement. With 5 open roles it is hiring more than 20% of the 226 Series A startups on JustBacked (median: 9). In total it has raised $116M over 1 round from 1 investors.
From BrainChild Bio's own hiring system, by posting date. Tracked since Oct 4, 2026; roles that closed before then aren't counted.
BrainChild Bio develops chimeric antigen receptor T-cell therapies engineered to treat tumors of the central nervous system.
Families facing brain tumors have few options, and a therapy that works inside the central nervous system could change that for children first, then adults. BrainChild Bio, a Seattle biotechnology company, is backed by a $116M Series A that outsizes 93% of rounds at its stage, with Seattle Children's in the syndicate. Four open roles in legal, hardware and operations say the build-out has started.
JustBacked's take, based on BrainChild Bio's own site and its funding and hiring data.
Hiring velocity
Where they're hiring
BrainChild Bio · Series A
United States · Remote
$205K–$275K
Posted 16 days ago· Nov 4
BrainChild Bio · Series A
Seattle, WA
$100K–$115K
Posted 31 days ago· Oct 20
BrainChild Bio · Series A
Seattle, WA
$90K–$105K
Posted 31 days ago· Oct 20
BrainChild Bio · Series A
Seattle, WA
$195K–$215K
Posted 45 days ago· Oct 6
BrainChild Bio · Series A
United States · Remote
$190K–$210K
Posted 85 days ago· Aug 27
Source: brainchildbio.com, checked daily.